| Order code | Description | Components | Norm |
| QC134-1M | Liquid Cardiolipin-M control | Liquid IgM autoantibodies to the cardiolipin in human serum(50MPL/mL) | 100ul/bottle |
| QC134-1L | Liquid Cardiolipin-M control | Liquid IgM autoantibodies to the cardiolipin in human serum(25MPL/mL) | 100ul/bottle |
| QC133-1M | Liquid β2-Glyco-M control | Liquid IgM autoantibodies to the β2-glycoprotein 1 in human serum(50MPL/mL) | 100ul/bottle |
| QC133-1L | Liquid β2-Glyco-M control | Liquid IgM autoantibodies to the β2-glycoprotein 1 in human serum(25MPL/mL) | 100ul/bottle |
| QC132-1M | Liquid Cardiolipin-G control | Liquid IgG autoantibodies to the cardiolipin in human serum(50GPL/mL) | 100ul/bottle |
| QC132-1L | Liquid Cardiolipin-G control | Liquid IgG autoantibodies to the cardiolipin in human serum(25GPL/mL) | 100ul/bottle |
| QC131-1M | Liquid β2-Glyco-G control | Liquid IgG autoantibodies to the β2-glycoprotein 1 in human serum(50GPL/mL) | 100ul/bottle |
| QC131-1L | Liquid β2-Glyco-G control | Liquid IgG autoantibodies to the β2-glycoprotein 1 in human serum(25GPL/mL) | 100ul/bottle |
| QC130-1 | Liquid aPL negative control | Liquid aPL negative in human serum | 100ul/bottle |
